FCI
BMRN icon

Financial Counselors Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Financial Counselors Inc’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,298
Closed -$1.03M – 493
2017
Q2 		$1.03M Buy
11,298
+5,002
+79% +$455K 0.05% 281
2017
Q1 		$553K Sell
6,296
-90
-1% -$8.01K 0.03% 329
2016
Q4 		$529K Buy
+6,386
New +$549K 0.03% 327

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Financial Counselors Inc's BMRN Position: Q3 2017 in Review

Financial Counselors Inc sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2017, closing a stake of 11,298 shares — an estimated $1.03M sold.

Financial Counselors Inc first reported a position in BMRN in Q4 2016 and held it in 3 quarters. The position peaked at $1.03M in Q2 2017. 411 funds tracked by Wall St. Rank hold BMRN as of Q3 2017.

  • Financial Counselors Inc reported no remaining BioMarin Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Financial Counselors Inc sold 11,298 BioMarin Pharmaceuticals shares in Q3 2017, an estimated $1.03M.
  • Financial Counselors Inc first reported a position in BioMarin Pharmaceuticals in Q4 2016 and held it in 3 quarters.
  • Financial Counselors Inc's BioMarin Pharmaceuticals position peaked at $1.03M in Q2 2017.
  • 411 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2017.

Based on Financial Counselors Inc's 13F filing for Q3 2017, filed 13 Nov 2017.